Volpara Blog

PCP Counseling Patient

The Medical Necessity Letter: Advocating to Get Your Patients the Care They Need


Deb Hamel

How We Simplified Our ACR Accreditation with VolparaEnterprise

Derry Imaging receives renewal from ACR in just 11 days

Residual breast density

What is Residual Breast Density and Why it Matters in the Tyrer-Cuzick Risk Model

Breast density is an independent risk factor associated with the development of breast cancer.1, 2, 3, 4 Adding breast density to risk calculation has been shown to more accurately predict...

Volpara Covid19

COVID-19 Resources from Volpara Solutions

From the very beginning, Volpara Solutions entered the healthcare space to help. In a very real sense, our job has been to support you, to help with your efforts to...


Understanding the Use of Competing Mortality in Risk Assessment

To understand the risk of developing a disease such as breast cancer, studies test the predictive value of risk factors.

Tyrer Cuzick screenshot

Guide to Best Practices for Clinical Tyrer-Cuzick Risk Assessment

Breast screening is rapidly moving into an era of personalized care, where prevention, early detection, and treatment are guided by risk assessment.


How to Get Your Patients on Their Best Screening Pathway

The need for greater participation in breast cancer screening programs cannot be overlooked. An estimated 1 in 8 women will develop breast cancer in her lifetime.


Advancing Mammography Quality Assurance through Professional Collaboration

Katie Kaminski, MRT (R), is the lead mammography technologist for Mayfair Diagnostics in Alberta, Canada. Katie has been with Mayfair since 2012 and is responsible for maintaining Mayfair’s screening and...

Ob Gyn Volpara

The Critical Role of OB-GYN Providers and Primary Care Physicians in Breast Care

The recommended frequency of breast cancer screening and the age at which a woman should begin mammography remain sources of considerable debate.


The FDA Will Require Breast Density Notification. Now What?

Last week, the United States’ Food and Drug Administration (FDA) agency proposed a rule that would inform women of their breast density.

Recent Posts

1 2 3 4 8